GUFIC BIOSCIENCES Financial Statement Analysis
|
||
The Revenues of GUFIC BIOSCIENCES have increased by 0% YoY .
The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has increased by 0 YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
GUFIC BIOSCIENCES Last 5 Annual Financial Results
[BOM: 509079|NSE : GUFICBIO]
Consolidated | Mar2024 |
---|---|
Revenues | ₹0.00 Cr |
Expenses | ₹0.00 Cr |
Operating Profit (Excl OI) | ₹0.00 Cr |
Other Income | ₹0.00 Cr |
Interest | ₹0.00 Cr |
Depreciation | ₹0.00 Cr |
Profit Before Tax | ₹0.00 Cr |
Profit After Tax | ₹0.00 Cr |
Consolidated Net Profit | ₹0.00 Cr |
Earnings Per Share (Rs) | ₹8.59 |
PAT Margin (%) | 9.16 |
ROE(%) | 16.17 |
ROCE(%) | 15.42 |
Total Debt/Equity(x) | 0.60 |
Key Financials |
||
Market Cap | : | ₹ 3,865.1 Cr |
Revenue (TTM) | : | ₹ 819.8 Cr |
Net Profit(TTM) | : | ₹ 69.7 Cr |
EPS (TTM) | : | ₹ 6.9 |
P/E (TTM) | : | 55.5 |
Industry Peers & Returns | 1W | 1M | 1Y |
GUFIC BIOSCIENCES | 10.1% | 6.3% | 7.5% |
SUN PHARMACEUTICAL INDUSTRIES | 1.8% | 3.4% | 7.3% |
DIVIS LABORATORIES | -0.7% | 3.8% | 49.3% |
CIPLA | -0.2% | -1.1% | -2.8% |
TORRENT PHARMACEUTICALS | 5.8% | 8.6% | 17.3% |
DR REDDYS LABORATORIES | 0.7% | -3.8% | -7.3% |
MANKIND PHARMA | 2.4% | 12.2% | 22.2% |
ZYDUS LIFESCIENCES | 0.2% | 2.5% | -18.5% |
LUPIN | 3.3% | 0.1% | 5.3% |
GUFIC BIOSCIENCES Revenues
[BOM: 509079|NSE : GUFICBIO]
Y-o-Y | 0 % |
5 Yr CAGR | 0 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹0.00 Cr | - |
GUFIC BIOSCIENCES Operating Profit
[BOM: 509079|NSE : GUFICBIO]
Y-o-Y | 0 |
5 Yr CAGR | 0 |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹0.00 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 0 |
5 Yr CAGR | 0 |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 0% | - |
GUFIC BIOSCIENCES Profit After Tax
[BOM: 509079|NSE : GUFICBIO]
Y-o-Y | 0 |
5 Yr CAGR | 0 |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹0.00 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 0 |
5 Yr CAGR | 0 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 9.16 % | - |
GUFIC BIOSCIENCES Earnings Per Share (EPS)
[BOM: 509079|NSE : GUFICBIO]
Y-o-Y | 0 |
5 Yr CAGR | 0 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹8.59 | - |
GUFIC BIOSCIENCES Return on Capital Employed (ROCE)
[BOM: 509079|NSE : GUFICBIO]
Y-o-Y | 0 |
5 Yr CAGR | 0 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | 15.42% | - |
GUFIC BIOSCIENCES Share Price vs Sensex
Current Share Price | : | ₹385.4 |
Current MarketCap | : | ₹ 3,865.1 Cr |
Updated EOD on | : | Jul 17,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUFIC BIOSCIENCES | 10.1% |
6.3% |
7.5% |
SENSEX | -1.1% |
0.8% |
2.2% |
GUFIC BIOSCIENCES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 6.4% | 8.9% | 7.5% |
BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
BSE HEALTHCARE | 2.6% | 4.7% | 18.3% |
BSE SMALLCAP | 1.4% | 4.6% | 3% |
You may also like the below Video Courses
FAQ about GUFIC BIOSCIENCES Financials
How the annual revenues of GUFIC BIOSCIENCES have changed ?
The Revenues of GUFIC BIOSCIENCES have increased by 0% YoY .
How the Earnings per Share (EPS) of GUFIC BIOSCIENCES have changed?
The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has increased by 0 YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs